INSUBCONTINENT EXCLUSIVE:
radiopharmaceuticals to Turkey.Eslami made the remarks in a meeting with Hicabi Kirlangic, the Turkish ambassador to Iran.The AEOI chief
experiences.Praising the long-standing ties between Iran and Turkey, Eslami noted that the geographical proximity of the two nations has
Tehran is now ready to train nuclear experts and transfer the expertise of the AEOI subsidiaries in terms of operating, maintaining, and
affinities, saying that Turkiye has a transparent position on the use of peaceful nuclear energy and Ankara supports the right of different
countries, including Iran, to develop nuclear energy for civilian uses.In remarks earlier this month, Eslami indicated that Iran will
quickly become a center for the manufacturing and export of radiopharmaceuticals.The manufacturing capacity in this scientific field might
treatment of illnesses.The AEOI director declared Iran had wanted to become a major producer of deuterium pharmaceuticals in December
2022.In April 2021, the AEOI began operating the second phase of its deuterium production unit at the Arak heavy water reactor facility in
the central region of Iran.
